Sara McAllister
Women's Health · Kansas City, MONPI 1518449065
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Mayne Pharma Commercial LLC at 27.1% of the total.
Across 68 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$335
- AbbVie$320
- Novo Nordisk$142
- Hologic Sales And Service, LLC$141
- Exeltis, USA Inc.$96
- Organon$94
- plus $108 from 5 others
What the payments were for
- Food & beverage$1,235100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 28 | $335 |
| AbbVie | 15 | $320 |
| Novo Nordisk | 4 | $142 |
| Hologic Sales And Service, LLC | 2 | $141 |
| Exeltis, USA Inc. | 6 | $96 |
| Organon | 8 | $94 |
| Abiomed | 1 | $29 |
| Myriad Women's Health, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Chiesi USA, Inc. | 1 | $19 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$123
How this compares
$1,235 in reported general payments places this provider in the 70th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $1,254 |
| Triamcinolone Acetonide | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other women's health in Kansas City
- Jacquelyn WittKansas City$1K
- Maria HapkeKansas City$1K
- Julie MaybergerKansas City$1K
- Kathryn SimoneBlue Springs$192K
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Karla WilmotIndependence$22K
- Janice EislebenSaint Louis$16K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.